T. R. Halfdanarson
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
A Phase II randomized trial of panitumumab, erlotinib, and gemcitabine versus rrlotinib and hemcitabine in patients with nntreated, metastatic pancreatic adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
.
The oncologist.
2019
Contact
full name
T. R.
Halfdanarson
Quick Info
Collaboration
Co-author network
Map of science
